Given the potential breadth of upside, retail investors may consider a straightforward approach of acquiring UNH stock in the open market. However, for speculators interested in leverage, market makers appear to be offering a rather generous payout for the 310/320 bull call spread expiring Oct. 17.

UnitedHealth Group has attracted major contrarian investors like Buffett, Burry, and Simons. Click here to read why UNH stock is a Buy.

UnitedHealth Group (UNH) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.

Berkshire’s Big Bet on UnitedHealth Berkshire Hathaway’s (NYSE:BRK-A)(NYSE:BRK-B) release yesterday of its latest 13F filing sent ripples through the market as it revealed a new 5 million share stake in UnitedHealth Group (NYSE:UNH) worth approximately $1.

I initiate my coverage on UNH with a hold rating. Despite attractive valuation, with the P/E near 2014 levels and EV/EBITDA ~30% below sector median,

UnitedHealth Group Incorporated (NYSE:UNH) is one of the 9 Best NYSE Stocks to Buy According to Hedge Funds. On August 13, UnitedHealth Group Incorporated (NYSE:UNH) announced that its board of directors declared a cash dividend of $2.

Year to date, the stock has fallen by nearly 45%, which is by no means normal for the healthcare stock. In fact, this is the worst it has performed since the Great Recession, when it tumbled by more than 54% in 2008.

UnitedHealth Group (UNH) ended the recent trading session at $278.58, demonstrating a -4.76% change from the preceding day's closing price. This change lagged the S&P 500's 0.07% gain on the day.

Key Points in This Article: UnitedHealth Group (UNH), the largest U.S. health insurer, has faced a turbulent 2025 with a series of misfortunes that cut UNH stock in half.